Impact of 5-alpha reductase inhibitors on pre-biopsy MRI interpretation: effects on PI-RADS assessment and local staging
Canadian Journal of Urology · 2026 · 33 (5) · 1107-1122
DOI: 10.32604/cju.2026.073468 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Canadian Journal of Urology, 2026. Verfasst von Arianna Tumminello und 16 weiteren Autor:innen. Beteiligte Einrichtung: Urology Clinic, Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padova, Padova, Italy. Hauptthemen laut MEDLINE: 5-alpha Reductase Inhibitors, Prostatic Neoplasms, Prostatic Hyperplasia, Multiparametric Magnetic Resonance Imaging.
Abstract (Originalsprache)
5-alpha reductase inhibitors (5-ARIs) are widely prescribed for the management of benign prostatic hyperplasia and are known to induce morphological and metabolic changes in prostatic tissue. This narrative review summarizes current evidence on the impact of 5-ARI therapy on multiparametric magnetic resonance imaging (mpMRI) findings and the potential clinical implications. While some studies report reduced discrimination on T2-weighted and apparent diffusion coefficient (ADC) metrics after long-term exposure, others suggest improved lesion visibility due to a more homogeneous benign background. Most studies found no significant difference in the Prostate Imaging Reporting and Data System (PI-RADS) lesion distribution between 5-ARI users and non-users. However, conflicting evidence exists regarding mpMRI sensitivity and specificity in 5-ARI-treated patients. Limited data is available on the effect of 5-ARIs on local staging accuracy. Overall, the effect of 5-ARIs on prostate mpMRI interpretation appears complex, highlighting the need for prospective studies and treatment-adjusted risk assessment tools to support clinical decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Urology Clinic, Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padova, Padova, Italy.
- Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples "Federico II", Naples, Italy.
- Radiology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
- Radiology Unit, Department of Radiology, University Hospital of Padua, Padua, Italy.
- Surgical Pathology & Cytopathology Unit, Department of Medicine (DIMED), University of Padova, Padova, Italy.
ORCID-Profile: Fabio Zattoni
Zitieren
APA
Tumminello, A., Reitano, G., Tonet, E., Basso, G., Crocetto, F., Bednarova, I., Caumo, F., Todisco, M., Lauro, A., Lacognata, C., Galuppini, F., Conti, G., Betto, G., Iafrate, M., Novara, G., Dal Moro, F., & Zattoni, F. (2026). Impact of 5-alpha reductase inhibitors on pre-biopsy MRI interpretation: effects on PI-RADS assessment and local staging. Canadian Journal of Urology, 33(5), 1107-1122. https://doi.org/10.32604/cju.2026.073468
Vancouver
Tumminello A, Reitano G, Tonet E, Basso G, Crocetto F, Bednarova I, et al. Impact of 5-alpha reductase inhibitors on pre-biopsy MRI interpretation: effects on PI-RADS assessment and local staging. Canadian Journal of Urology. 2026;33(5):1107-1122. doi:10.32604/cju.2026.073468
BibTeX
@article{Tumminello2026,
author = {Tumminello, Arianna and Reitano, Giuseppe and Tonet, Elisa and Basso, Giovanni and Crocetto, Felice and Bednarova, Iliana and Caumo, Francesca and Todisco, Matteo and Lauro, Alberto and Lacognata, Carmelo and Galuppini, Francesca and Conti, Giorgio De and Betto, Giovanni and Iafrate, Massimo and Novara, Giacomo and Dal Moro, Fabrizio and Zattoni, Fabio},
title = {Impact of 5-alpha reductase inhibitors on pre-biopsy MRI interpretation: effects on PI-RADS assessment and local staging},
journal = {Canadian Journal of Urology},
year = {2026},
volume = {33},
number = {5},
pages = {1107--1122},
doi = {10.32604/cju.2026.073468}
}
EUVIMED